Omalizumab in the treatment of aspirin-exacerbated respiratory disease

J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):459-60. doi: 10.1016/j.jaip.2015.01.012. Epub 2015 Jan 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Asthma, Aspirin-Induced / diagnosis
  • Asthma, Aspirin-Induced / drug therapy*
  • Asthma, Aspirin-Induced / immunology
  • Asthma, Aspirin-Induced / physiopathology
  • Female
  • Humans
  • Lung / drug effects*
  • Lung / immunology
  • Lung / physiopathology
  • Middle Aged
  • Omalizumab / therapeutic use*
  • Remission Induction
  • Treatment Outcome

Substances

  • Anti-Allergic Agents
  • Omalizumab